ARWR
Arrowhead Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$10.70B
P/E Ratio
47.74
EPS
$1.60
Beta
1.29
52W High
$76.76
52W Low
$12.44
50-Day MA
$63.74
200-Day MA
$48.58
Dividend Yield
—
Profit Margin
18.50%
Forward P/E
97.09
PEG Ratio
-1.32
About Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
Fundamentals
| Revenue (TTM) | $1.09B |
| Gross Profit (TTM) | $1.09B |
| EBITDA | $325.65M |
| Operating Margin | 15.50% |
| Return on Equity | 75.50% |
| Return on Assets | 14.30% |
| Revenue/Share (TTM) | $7.97 |
| Book Value | $4.14 |
| Price-to-Book | 18.43 |
| Price-to-Sales (TTM) | 9.80 |
| EV/Revenue | 9.05 |
| EV/EBITDA | 26.66 |
| Quarterly Earnings Growth (YoY) | 9.80% |
| Quarterly Revenue Growth (YoY) | 10461.00% |
| Shares Outstanding | $140.03M |
| Float | $122.04M |
| % Insiders | 3.78% |
| % Institutions | 79.16% |
Historical Volatility
HV 10-Day
41.56%
HV 20-Day
47.34%
HV 30-Day
53.42%
HV 60-Day
46.59%
HV Rank
34.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($84.50 target)
3
Strong Buy7
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026